Literature DB >> 11696990

The effects of collagen fragments on the extracellular matrix metabolism of bovine and human chondrocytes.

L Jennings1, L Wu, K B King, H Hämmerle, G Cs-Szabo, J Mollenhauer.   

Abstract

Cartilage matrix degradation generates collagen type II fragments. The objective of this study is to explore the possibility that these collagen fragments may be part of an endogenous metabolic feedback. Initially, collagen fragments were extracted from normal or osteoarthritic cartilage, as part of a matrix fragment preparation. Later, collagen fragments were generated by digestion of bovine collagen type II with bacterial collagenase (col2f). These fragments were added to cultures of isolated chondrocytes (bovine and human) and cartilage explants (human). In a dose-dependent manner, col2f caused inhibition of cell attachment to collagen, inhibition of collagen synthesis, and induction of matrix degradation. In addition, when col2f were added to human cartilage explants, an induction of gelatinase activity was detected in the media. These data sets present first evidence that degradation products of collagen may be directly involved in the regulation of cartilage homeostasis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11696990     DOI: 10.3109/03008200109014250

Source DB:  PubMed          Journal:  Connect Tissue Res        ISSN: 0300-8207            Impact factor:   3.417


  18 in total

Review 1.  New functional roles for non-collagenous domains of basement membrane collagens.

Authors:  Nathalie Ortega; Zena Werb
Journal:  J Cell Sci       Date:  2002-11-15       Impact factor: 5.285

2.  Endoplasmic reticulum stress (ER-stress) by 2-deoxy-D-glucose (2DG) reduces cyclooxygenase-2 (COX-2) expression and N-glycosylation and induces a loss of COX-2 activity via a Src kinase-dependent pathway in rabbit articular chondrocytes.

Authors:  Seon-Mi Yu; Song-Ja Kim
Journal:  Exp Mol Med       Date:  2010-11-30       Impact factor: 8.718

3.  A hypothesis for the origin and pathogenesis of rheumatoid diseases.

Authors:  Wolfgang Lorenz; Gerold Sigrist; Mehdi Shakibaei; Ali Mobasheri; Christoph Trautmann
Journal:  Rheumatol Int       Date:  2005-12-14       Impact factor: 2.631

Review 4.  The roles of catabolic factors in the development of osteoarthritis.

Authors:  Dominick J Blasioli; David L Kaplan
Journal:  Tissue Eng Part B Rev       Date:  2013-12-11       Impact factor: 6.389

5.  Heterologous Type I Collagen as an Add-on Therapy to Narrowband Ultraviolet B for the Treatment of Vitiligo: A Pilot Study.

Authors:  Aikaterini Gkouvi; Electra Nicolaidou; Andreas Corbo; Gennaro Selvaggi; Antonis Tsimpidakis; Styliani Mastraftsi; Stamatios Gregoriou
Journal:  J Clin Aesthet Dermatol       Date:  2021-06-01

Review 6.  Cartilage destruction by matrix degradation products.

Authors:  Tadashi Yasuda
Journal:  Mod Rheumatol       Date:  2006       Impact factor: 3.023

7.  Biomechanical modulation of collagen fragment-induced anabolic and catabolic activities in chondrocyte/agarose constructs.

Authors:  Tina T Chowdhury; Ronny M Schulz; Sonpreet S Rai; Christian B Thuemmler; Nico Wuestneck; Augustinus Bader; Gene A Homandberg
Journal:  Arthritis Res Ther       Date:  2010-05-12       Impact factor: 5.156

Review 8.  Analysing the role of endogenous matrix molecules in the development of osteoarthritis.

Authors:  Nidhi Sofat
Journal:  Int J Exp Pathol       Date:  2009-10       Impact factor: 1.925

9.  TGF-beta inhibits IL-1beta-activated PAR-2 expression through multiple pathways in human primary synovial cells.

Authors:  Shin-Han Tsai; Ming-Thau Sheu; Yu-Chih Liang; Hsiu-Tan Cheng; Sheng-Shiung Fang; Chien-Ho Chen
Journal:  J Biomed Sci       Date:  2009-10-23       Impact factor: 8.410

10.  Collagen metabolism of human osteoarthritic articular cartilage as modulated by bovine collagen hydrolysates.

Authors:  Saskia Schadow; Hans-Christian Siebert; Günter Lochnit; Jens Kordelle; Markus Rickert; Jürgen Steinmeyer
Journal:  PLoS One       Date:  2013-01-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.